Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Patent: 5,563,132

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 5,563,132
Title: Two-step cancer treatment method
Abstract:A two-step cancer treatment method consisting of the initial administration of a cancer-localizing peroxide-reactive metal-ion containing compound, and then administering a peroxide compound to the patient after allowing sufficient time for the localization to the cancer of the metal-ion containing compound to occur. The product of the chemical reaction between the cancer-localizing metal-ion containing compound, and the peroxide compound is an oxidant species which acts to destroy the cancer.
Inventor(s): Bodaness; Richard S. (Bethesda, MD)
Application Number:08/263,186
Patent Claims:see list of patent claims

Details for Patent 5,563,132

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. PANHEMATIN hemin for injection For Injection 101246 1983-07-20 ⤷  Try it Free 2040-01-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.